Psilocybin infusion (Beckley Psytech)

N/A

Report date: 2024/02/06 13:05:25

Base Information

Drug NamePsilocybin infusion (Beckley Psytech)
Drug Alias NameELE-101ELE-PsiloELE-Psilo+
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor agonistsSerotonin 2a (5-HT2a) receptor agonists
TargetsSerotonin 1a (5-HT1a) receptorSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsDepressive Disorder, MajorDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEleusis Holdings Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsDepressive Disorder, MajorDepression
Inactive IndicationsN/A

Other Information

ATC CodeN/A